GO:0072558 NLRP1 inflammasome complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0072558 (NLRP1 inflammasome complex) is a cellular component defined as an inflammasome complex consisting of NLRP1 (NALP1) and caspase-1 or caspase-5, with potassium ion efflux appearing essential for activation.
The NLRP1 inflammasome is a molecular platform that triggers activation of inflammatory caspases and processing of proIL-1beta, as first described for inflammasomes generally.
NLRP1 inflammasome activation is linked to depressive-like behaviors in mice, and autophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behaviors.
The NLRP1 inflammasome plays a role in skin cancer and inflammatory skin diseases, making it a potential therapeutic target.
Viral proteins, such as the non-structural protein of SFTSV, can activate NLRP1 and CARD8 inflammasomes by disrupting the DPP9-mediated ternary complex.
Exosome-inflammasome crosstalk is an emerging area, with exosomes influencing inflammatory responses that involve inflammasome complexes.

Description

The NLRP1 inflammasome complex (GO:0072558) is a cellular component that serves as a molecular platform for innate immune signaling. It is defined as an inflammasome complex consisting of two key components, NLRP1 (also known as NALP1) and caspase-1 or caspase-5, and its activation appears to require potassium ion efflux. This complex is part of the broader inflammasome family, which triggers activation of inflammatory caspases and processing of proIL-1beta, a central event in inflammation. Understanding GO:0072558 is essential for researchers studying innate immunity, inflammatory diseases, and cell death pathways. The NLRP1 inflammasome has been implicated in diverse physiological and pathological contexts, including chronic stress-induced depressive-like behaviors in mice and autophagy dysfunction-linked depressive-like behaviors. Moreover, its role in skin cancer and inflammatory skin diseases highlights its clinical relevance. Recent structural and mechanistic studies have provided insights into inflammasome assembly and regulation, including the disruption of the DPP9-mediated ternary complex by viral proteins. Exosome-inflammasome crosstalk further underscores the complex regulatory networks involving inflammasomes in inflammatory responses. As a result, GO:0072558 is a critical entity for both basic and translational research.

NLRP1 inflammasome complex At A Glance

GO ID GO:0072558
GO term NLRP1 inflammasome complex
Ontology cellular_component
Synonym NALP1 inflammasome complex
Major function Molecular platform triggering activation of inflammatory caspases and processing of proIL-1beta
Components NLRP1 (NALP1) and caspase-1 or caspase-5
Activation requirement Potassium ion efflux appears to be essential
Associated diseases Depressive-like behaviors, skin cancer, inflammatory skin diseases
Regulatory mechanism Disruption of DPP9-mediated ternary complex by viral proteins

What Is GO:0072558?

GO:0072558 (NLRP1 inflammasome complex) is a cellular component defined by QuickGO as an inflammasome complex that consists of two components, NLRP1 (NALP1) and caspase-1 or caspase-5. The exact mechanisms of NLRP1 activation remain obscure, but potassium ion efflux appears to be essential. This complex is synonymous with the NALP1 inflammasome complex and functions as a molecular platform for inflammatory caspase activation and proIL-1beta processing.

Why Is NLRP1 inflammasome complex Important in Cell Biology?

The NLRP1 inflammasome complex (GO:0072558) is important because it represents a key innate immune sensing platform that links pathogen detection and cellular stress to inflammatory caspase activation and cytokine processing. Its dysfunction or dysregulation has been associated with major human conditions, including chronic stress-induced depressive-like behaviors, autophagy-related depressive-like behaviors, and skin cancer and inflammatory skin diseases. Additionally, viral pathogens can exploit NLRP1 inflammasome regulation by disrupting the DPP9-mediated ternary complex. Understanding this complex is therefore critical for developing therapeutic strategies targeting inflammation and immune-related disorders.
Central to innate immunity as a molecular platform for inflammatory caspase activation.
Implicated in chronic stress-induced depressive-like behaviors in mice.
Linked to autophagy dysfunction and depressive-like behaviors.
Plays a role in skin cancer and inflammatory skin diseases.
Targeted by viral proteins that disrupt the DPP9-mediated ternary complex.
Involved in exosome-inflammasome crosstalk during inflammatory responses.
Potassium ion efflux is essential for its activation, highlighting ion flux as a regulatory node.
Provides a potential therapeutic target for inflammatory and psychiatric disorders.
Structural insights from inflammasome studies inform drug development.
Relevant to understanding pathogen-host interactions, as shown for SFTSV.

Core Biology of NLRP1 inflammasome complex (GO:0072558)

What Happens During NLRP1 inflammasome complex Activation?
In simple terms: When the NLRP1 inflammasome is triggered, it activates caspases that cause inflammation.
The NLRP1 inflammasome complex functions as a molecular platform that triggers activation of inflammatory caspases and processing of proIL-1beta. Activation of the NLRP1 inflammasome is associated with potassium ion efflux, which appears to be essential for its function. This process leads to the cleavage of pro-inflammatory cytokines and can drive inflammatory responses. In mice, NLRP1 inflammasome activation contributes to chronic stress-induced depressive-like behaviors, and autophagy dysfunction can exacerbate NLRP1 inflammasome-linked depressive-like behaviors.
Structure and Composition of NLRP1 inflammasome complex
In simple terms: The NLRP1 inflammasome is made of two main proteins: NLRP1 and caspase-1 or caspase-5.
According to the QuickGO definition, the NLRP1 inflammasome complex consists of two components: NLRP1 (NALP1) and caspase-1 or caspase-5. The complex is a cellular component (GO:0072558) that assembles as a platform for inflammatory signaling. Structural and mechanistic studies of inflammasomes have revealed insights into how these complexes are organized and regulated. The DPP9-mediated ternary complex regulates NLRP1, and its disruption by viral proteins can activate NLRP1 and CARD8 inflammasomes.
Molecular Mechanism of NLRP1 inflammasome complex
In simple terms: The NLRP1 inflammasome works by activating caspase-1 or caspase-5, which then process inflammatory molecules.
The molecular mechanism of the NLRP1 inflammasome involves the activation of caspase-1 or caspase-5, which in turn process proIL-1beta to its active form. Potassium ion efflux is a critical trigger for this activation. The exact mechanisms of NLRP1 activation remain obscure, but potassium ion efflux appears to be essential. Recent studies have shown that the non-structural protein of SFTSV activates NLRP1 and CARD8 inflammasomes by disrupting the DPP9-mediated ternary complex. This highlights a viral strategy to manipulate inflammasome activity.
Regulation of NLRP1 inflammasome complex
In simple terms: The NLRP1 inflammasome is controlled by other proteins and cellular conditions.
Regulation of the NLRP1 inflammasome involves the DPP9-mediated ternary complex, which can be disrupted by viral proteins such as the non-structural protein of SFTSV, leading to inflammasome activation. Autophagy dysfunction has been linked to NLRP1 inflammasome-associated depressive-like behaviors, suggesting that autophagy regulates this complex. Additionally, exosome-inflammasome crosstalk may influence inflammatory responses involving inflammasomes. These regulatory layers ensure tight control of inflammasome activation.
Role in Inflammatory Responses and Disease
In simple terms: The NLRP1 inflammasome is involved in inflammation and several diseases.
The NLRP1 inflammasome complex is implicated in inflammatory responses and disease pathogenesis. It contributes to chronic stress-induced depressive-like behaviors in mice and is linked to autophagy dysfunction-associated depressive-like behaviors. In the skin, the NLRP1 inflammasome plays a role in skin cancer and inflammatory skin diseases. Exosome-inflammasome crosstalk further connects inflammasome activity to broader inflammatory networks. These findings underscore the importance of GO:0072558 in human health and disease.

Key Genes Involved in GO:0072558 NLRP1 inflammasome complex

The following genes and proteins are key components or regulators of the NLRP1 inflammasome complex (GO:0072558) and its associated pathways.
GeneMajor RoleResearch Relevance
NLRP1Core component of the inflammasome complexCentral to inflammasome assembly and activation
CASP1Caspase-1, effector protease of the inflammasomeProcesses proIL-1beta and triggers inflammation
CASP5Caspase-5, alternative effector proteasePart of the NLRP1 inflammasome complex
DPP9Regulator forming ternary complex with NLRP1Disruption by viral proteins activates NLRP1
CARD8Related inflammasome sensorActivated alongside NLRP1 by SFTSV protein
IL1BPro-inflammatory cytokine processed by inflammasomeReadout of inflammasome activation
ATG5Autophagy-related proteinAutophagy dysfunction linked to NLRP1 inflammasome
ATG7Autophagy-related proteinAutophagy dysfunction linked to NLRP1 inflammasome
BECN1Autophagy regulatorPotential link to NLRP1 inflammasome regulation
MAP1LC3BAutophagosome markerAutophagy dysfunction studies
SQSTM1Autophagy receptorAutophagy dysfunction studies
NLRP3Related inflammasome sensorComparative studies and inhibitor development
PYCARDAdaptor protein in inflammasomesInflammasome assembly and signaling
GSDMDGasdermin D, pyroptosis executorDownstream of inflammasome activation
IL18Cytokine processed by inflammasomeInflammatory readout
TXNIPRedox regulatorPotential inflammasome regulator
NFKB1Transcription factor for inflammasome primingInflammatory gene expression

How Is NLRP1 inflammasome complex Regulated?

The NLRP1 inflammasome complex is regulated at multiple levels. The DPP9-mediated ternary complex acts as a brake on NLRP1 activation, and its disruption by viral proteins such as the SFTSV non-structural protein leads to inflammasome activation. Autophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behaviors, indicating that autophagic pathways regulate this complex. Additionally, exosome-inflammasome crosstalk may modulate inflammatory responses involving inflammasomes. Potassium ion efflux is a critical activation trigger, as noted in the QuickGO definition. These regulatory mechanisms ensure that NLRP1 inflammasome activity is tightly controlled under physiological conditions.

NLRP1 inflammasome complex and Human Disease

GeneDisease / BiologyPotential Experimental Model
NLRP1Depressive-like behaviorsChronic stress mouse model
NLRP1Autophagy-linked depressive-like behaviorsAutophagy dysfunction mouse model
NLRP1Skin cancer and inflammatory skin diseasesSkin cancer cell lines and mouse models
NLRP1Viral infection (SFTSV)SFTSV infection models
NLRP1Inflammatory responsesExosome-inflammasome crosstalk models
NLRP1 inflammasome complex in Depressive-like Behaviors
The NLRP1 inflammasome complex contributes to chronic stress-induced depressive-like behaviors in mice. Autophagy dysfunction further exacerbates NLRP1 inflammasome-linked depressive-like behaviors, suggesting a mechanistic link between autophagy, inflammasome activation, and mood disorders. These findings highlight the NLRP1 inflammasome as a potential therapeutic target for depression.
NLRP1 inflammasome complex in Skin Cancer and Inflammatory Skin Diseases
The NLRP1 inflammasome plays a role in skin cancer and inflammatory skin diseases. Its activation in keratinocytes and other skin cells can drive inflammatory responses that contribute to disease pathogenesis. Targeting the NLRP1 inflammasome may offer new avenues for treating skin disorders.
NLRP1 inflammasome complex in Viral Infections
Viral proteins can activate the NLRP1 inflammasome. The non-structural protein of SFTSV activates NLRP1 and CARD8 inflammasomes by disrupting the DPP9-mediated ternary complex. This highlights how viruses can manipulate inflammasome pathways to their advantage, and suggests that NLRP1 inflammasome modulation could be relevant for antiviral strategies.
NLRP1 inflammasome complex and Exosome Crosstalk
Exosome-inflammasome crosstalk is an emerging area in inflammatory responses. Exosomes can carry inflammasome components or regulators, influencing the activation state of the NLRP1 inflammasome. Understanding this crosstalk may reveal new mechanisms of intercellular communication in inflammation.

From NLRP1 inflammasome complex-Related Genes to Experimental Models

Research QuestionSuitable Model
Does NLRP1 inflammasome drive depressive-like behaviors?NLRP1 knockout mice subjected to chronic stress
Does autophagy regulate NLRP1 inflammasome?Autophagy-related gene knockout mice
How does SFTSV protein activate NLRP1?Cells expressing SFTSV non-structural protein
What is the role of NLRP1 in skin cancer?Skin cancer cell lines with NLRP1 knockdown
Can exosomes modulate NLRP1 inflammasome?Exosome treatment in inflammasome reporter cells
What is the structural basis of NLRP1 inflammasome?Recombinant protein assembly and structural studies

How to Study the NLRP1 inflammasome complex Process

MethodWhat It MeasuresTypical Application
Western blotCaspase-1 activation and IL-1beta processingInflammasome activation in cell lysates
ImmunoprecipitationProtein-protein interactionsIdentifying NLRP1 complex components
Fluorescence microscopyInflammasome assembly and localizationVisualizing NLRP1 specks
CRISPR knockout screeningGene requirements for inflammasome activationIdentifying novel regulators
RNA-seqTranscriptional changesGene expression profiling upon activation
ProteomicsProtein composition and modificationsMapping inflammasome interactome
Flow cytometrySingle-cell caspase-1 activityQuantifying activation heterogeneity
Behavioral testsDepressive-like behaviorsAssessing NLRP1 role in mood
Methods to Study NLRP1 inflammasome complex
Studying the NLRP1 inflammasome complex requires a combination of biochemical, cellular, and in vivo approaches. Western blotting can detect caspase-1 activation and IL-1beta processing. Immunoprecipitation can identify complex components and interacting proteins. Fluorescence microscopy can visualize inflammasome assembly using tagged proteins. Animal models, such as NLRP1 knockout mice, are used to assess behavioral and inflammatory outcomes.
CRISPR Screening for NLRP1 inflammasome Regulators
CRISPR library screening can identify genes that regulate NLRP1 inflammasome activation. Genome-wide knockout screens coupled with inflammasome readouts, such as caspase-1 activity or IL-1beta secretion, can uncover novel regulators. These screens are particularly useful for identifying components of the DPP9-mediated ternary complex and other modulators.
Bioinformatics Approaches for NLRP1 inflammasome Research
Bioinformatics analyses of transcriptomic and proteomic data can reveal pathways and networks associated with NLRP1 inflammasome activity. RNA-seq of cells with NLRP1 activation can identify differentially expressed genes. Proteomic profiling of inflammasome complexes can identify post-translational modifications and interacting partners. These approaches complement experimental validation.
Imaging and Flow Cytometry for Inflammasome Studies
Imaging techniques, such as confocal microscopy, allow visualization of NLRP1 inflammasome assembly and localization. Flow cytometry can quantify inflammasome activation at the single-cell level using fluorescent probes for caspase-1 activity. These methods are valuable for studying heterogeneity in inflammasome responses.

How CRISPR Can Be Used to Study GO:0072558 NLRP1 inflammasome complex

Knockout

CRISPR knockout of NLRP1 or CASP1 can abolish NLRP1 inflammasome function, providing a clean background to study its role in inflammation and disease. NLRP1 knockout mice have been used to demonstrate the contribution of the inflammasome to depressive-like behaviors. Knockout of autophagy genes such as ATG5 or ATG7 can reveal crosstalk between autophagy and NLRP1 inflammasome.

Point Mutation

Point mutations can be introduced into NLRP1 or CASP1 to dissect specific domains or catalytic residues. For example, mutating the catalytic cysteine of caspase-1 can prevent cytokine processing while preserving complex assembly. Such models help distinguish between scaffolding and enzymatic functions.

Knock-in

Knock-in of tagged NLRP1 (e.g., GFP or HA) allows visualization and purification of the inflammasome complex. Tagged knock-in models are valuable for imaging studies and proteomic analyses. Knock-in of disease-associated mutations can model human conditions.

Overexpression

Overexpression of NLRP1 or its components can drive constitutive inflammasome activation, useful for studying downstream effects. Overexpression systems in cell lines enable biochemical studies of complex assembly and activation. However, careful controls are needed to avoid artifacts from supraphysiological levels.

How EDITGENE Supports NLRP1 inflammasome complex Research

Researchers studying NLRP1 inflammasome complex-related genes often need to determine whether a candidate gene is causally involved in inflammasome activation, inflammatory cytokine processing, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for NLRP1 inflammasome complex research.

Frequently Asked Questions About NLRP1 inflammasome complex

The NLRP1 inflammasome complex (GO:0072558) is a cellular component consisting of NLRP1 (NALP1) and caspase-1 or caspase-5, which acts as a molecular platform for inflammatory caspase activation and proIL-1beta processing.
Key genes include NLRP1, CASP1, CASP5, DPP9, CARD8, and IL1B, among others.
GO:0072558 functions as an inflammasome complex that triggers activation of inflammatory caspases and processing of proIL-1beta.
Activation requires potassium ion efflux and can be triggered by disruption of the DPP9-mediated ternary complex by viral proteins.
It is associated with depressive-like behaviors, skin cancer, inflammatory skin diseases, and viral infections.
NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors, and autophagy dysfunction exacerbates this.
Common methods include Western blot for caspase-1, immunoprecipitation, fluorescence microscopy, CRISPR screening, and animal behavioral tests.
NALP1 inflammasome complex is a synonym for the NLRP1 inflammasome complex (GO:0072558).
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect NLRP1 inflammasome biology.
The complex consists of NLRP1 (NALP1) and caspase-1 or caspase-5.

Conclusion

The NLRP1 inflammasome complex (GO:0072558) is a critical cellular component in innate immunity, with roles in inflammatory caspase activation and cytokine processing. Its involvement in depressive-like behaviors, skin diseases, and viral infections underscores its broad physiological and pathological significance. Continued research using advanced CRISPR models and screening approaches will further elucidate its mechanisms and therapeutic potential.

References

  1. 1. Song AQ et al.. 2020. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice.. J Neuroinflammation 17(1):178 PMID: 32513185
  2. 2. Zhu YJ et al.. 2024. Autophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behaviors in mice.. J Neuroinflammation 21(1):6 PMID: 38178196
  3. 3. Noonin C et al.. 2021. Exosome-inflammasome crosstalk and their roles in inflammatory responses.. Theranostics 11(9):4436-4451 PMID: 33754070
  4. 4. Fu J et al.. 2024. Mechanistic insights from inflammasome structures.. Nat Rev Immunol 24(7):518-535 PMID: 38374299
  5. 5. Coll RC et al.. 2015. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.. Nat Med 21(3):248-55 PMID: 25686105
  6. 6. Liu PP et al.. 2025. The non-structural protein of SFTSV activates NLRP1 and CARD8 inflammasome through disrupting the DPP9-mediated ternary complex.. PLoS Pathog 21(7):e1013258 PMID: 40608794
  7. 7. Calabrese L et al.. 2024. Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases.. Br J Dermatol 190(3):305-315 PMID: 37889986
  8. 8. Martinon F et al.. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.. Mol Cell 10(2):417-26 PMID: 12191486
Contact Us
*
*
*
*
How did you hear about us: